American Well Corp (AMWL) company profile
Close on Nov 17, 2026Market cap $190.50MP/E –Yield –
About American Well
Services-Business Services, NEC, SIC 7389
American Well Corporation, known as Amwell, provides an enterprise software platform that enables hybrid healthcare delivery across virtual, in-person, and automated settings. Its core offering, the Amwell Platform, delivers digital care capabilities including urgent care, virtual primary care, behavioral health services, chronic condition management, and specialty consultations. The company also supplies Carepoint devices and hardware peripherals to equip physical facilities, automated programs for patient engagement, and access to the Amwell Medical Group network for clinical staffing. Amwell serves health systems, health plans, employers, government entities, and healthcare innovators.
Amwell is headquartered in Boston, Massachusetts. Its affiliated clinician network, Amwell Medical Group, provides continuous clinical coverage across all 50 U.S. states. The company supports the digital care initiatives of approximately 80 large health systems and roughly 50 health plans that represent over 90 million covered individuals. Additionally, the platform has supported more than 37.6 million virtual care visits since the company's inception, including more than 4.5 million visits during 2025.
Summary of the business section of American Well's latest annual report, written by StockData.
Company profile
Company
- Legal name
- American Well Corp
- Founded
- 2006
- Headquarters
- Boston, MA
- Address
- 75 State Street, 26th Floor 02109
- Phone
- (617) 205-3500
- Website
- amwell.com
- Employees
- 562, Dec 31, 2025
- Industry
- Services-Business Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Boston, Massachusetts, United States
Stock & identifiers
- Ticker
- AMWL
- Exchange
- NYSE
- IPO date
- Sep 18, 2020
- Shares outstanding
- 17M, Jul 24, 2026
- Public float
- $125.00M, Jun 30, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-20 reverse, Jul 11, 2024
- SEC CIK
- 1393584
- CUSIP
- 03044L204
- ISIN
- US03044L2043
- FIGI
- BBG002R1JYY1
- Share class FIGI
- BBG002R1JYZ0
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Ido Schoenberg | Chairman, co-CEO, Director | 277,924 |
| Roy Schoenberg | Executive Vice Chairman, Director | 133,302 |
| Phyllis Gotlib | President, International | 257,424 |
| Mark Hirschhorn | Chief Financial Officer | 223,906 |
| Paul Francis McNeice | Chief Accounting Officer | 9,086 |
| Dmitry Zamansky | Chief Product & Tech. Officer | 224,178 |
| Vukasin Paunovich | EVP, Enterprise Platforms | 116,121 |
| Kurt Knight | Chief Operating Officer | 142,213 |
| Kathy Johnson Weiler | Chief Comm. & Growth Officer | 180,593 |
| Rivka Goldwasser | Director | 105,861 |
| Deborah C. Jackson | Director | 53,645 |
| Derek Ross | Director | 71,183 |
| Stephen J. Schlegel | Director | 69,054 |
| Delos M. Cosgrove | Director | 71,193 |
| Robert Thomas Webb | Director | 72,559 |
| Peter L. Slavin | Director | 56,561 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $4.16M | $3.77M | $2.90M | $1 | – |
| FY2024 Ido Schoenberg | $2.12M | $587.62K | $4.04M | $2 | – |
| FY2024 Roy Schoenberg | $2.68M | $1.15M | $4.04M | $2 | – |
| FY2023 Ido Schoenberg | $797.80K | -$9.13M | $3.08M | $6 | – |
| FY2023 Roy Schoenberg | $658.40K | -$9.27M | $3.08M | $6 | – |
| FY2022 | $16.16M | $7.08M | $6.42M | $12 | $170 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Ido Schoenberg Chairman, Chief Executive Officer (CEO) | $701.76K | – | $1.29M | $2.01M | $155.99K | $4.16M | +97% |
| Mark Hirschhorn Executive Vice President, Chief Financial Officer and Chief Operating Officer | $575.00K | – | – | $1.99M | $10.50K | $2.58M | -11% |
| Dan Zamansky Executive Vice President, Chief Product and Technology Officer | $401.06K | $100.00K | $2.20M | $502.56K | $10.50K | $3.21M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Sep 18, 2020
- Offer price
- $18.00
- Securities offered
- 41,222,222
- Gross proceeds
- $742.00M
- Exchange
- NYSE
- First trading day
- Sep 17, 2020
- First-day close
- $23.07+28.2%
- Lock-up ends (est.)
- Mar 16, 2021
“The initial public offering price is $18.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 562 full-time employees of which 77% are based in the United States, spread out across 42 states, 10% in Ireland, 4% in Israel, 7% in Colombia and 2% in the UK.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 21, 2026 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Jan 10, 2025 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 4, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Sep 18, 2020 | IPO | Initial public offering priced (424B4 prospectus) |
| Sep 14, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?